Çмú´ëȸ ¹ßÇ¥ ¿¬Á¦ ÃÊ·ÏÁ¢¼ö Àüü¸ñ·Ï
D - -3113
2015³â 10¿ù 23ÀÏ (±Ý)
ÀÌ°ú

ÁßÀÌ ±âÃÊ
08:00~08:50 Chairperson(s) : ±è¿µÈ£,¹Ú½Ã³»
 
 OTOP-06 08:00~08:10 Differential protein expression in congenital and acquired cholesteatomas...
....................ÀÌÈ­¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐ À̺ñÀÎÈÄ°ú±³½Ç©ö, ¿¬¼¼´ëÇб³ ÀÇ°ú´ëÇÐ À̺ñÀÎÈÄ°ú±³½Ç©÷
........½Å½ÂÈ£©ö,±è¼ºÇå©÷, ÃÖÀ翵©÷
 OTOP-07 08:10~08:20 Osteogenic effect of BMP coated PCL nano scaffold...
....................°í·Á´ëÇб³ ÀÇ°ú´ëÇÐ À̺ñÀÎÈÄ°ú±³½Ç
........¼ÛÀçÁØ, ±èÈñº¹, °íÀ±¿µ, 伺¿ø
 OTOP-08 08:20~08:30 Antifibrotic effect of dexamethasone/alginate coated silastic sheet in the middle ear ...
....................Àü³²´ëÇб³ ÀÇ°ú´ëÇÐ À̺ñÀÎÈÄ°ú±³½Ç©ö, ¼º±Õ°ü´ëÇб³ »ý¸í°øÇаú Biomechatronics©÷
........Àåöȣ©ö, Á¶¿ë¹ü©ö, ¾È½ÂÇö©÷,±è±ÙÇü©÷©ö
 OTOP-09 08:30~08:40 The role of group 3 innate lymphoid cells in otitis media rat model...
....................µ¿±¹´ë Àϻ꺴¿ø
........°ø¼ºÈ£, ¹ÚÁÖÇö, ÀÓÀ±¼º, ¹Ú¼®¿ø, Á¶Ã¢°Ç
 OTOP-10 08:40~08:50 Äɶóƾ À¯¹ß °ñÆı« ¸¶¿ì½º ¸ðµ¨°ú periostinÀÇ ¿ªÇÒ...
....................°æ»ó´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø À̺ñÀÎÈÄ°úÇб³½Ç
........Ç㵿±¸, ±èÁø¿ë, ¾È¼º±â